BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17068818)

  • 1. High resolution computerized tomography of the chest and pulmonary function testing in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis patients.
    Nasr SZ; Gordon D; Sakmar E; Yu X; Christodoulou E; Eckhardt BP; Strouse PJ
    Pediatr Pulmonol; 2006 Dec; 41(12):1129-37. PubMed ID: 17068818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of high resolution computerized tomography (HRCT) of the chest in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis lung disease.
    Nasr SZ; Sakmar E; Christodoulou E; Eckhardt BP; Streetman DS; Strouse PJ
    Pediatr Pulmonol; 2010 May; 45(5):440-9. PubMed ID: 20425851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study.
    Chuchalin A; Csiszér E; Gyurkovics K; Bartnicka MT; Sands D; Kapranov N; Varoli G; Monici Preti PA; Mazurek H
    Paediatr Drugs; 2007; 9 Suppl 1():21-31. PubMed ID: 17536872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests.
    Brody AS; Klein JS; Molina PL; Quan J; Bean JA; Wilmott RW
    J Pediatr; 2004 Jul; 145(1):32-8. PubMed ID: 15238903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tobramycin solution for inhalation on global ratings of quality of life in patients with cystic fibrosis and Pseudomonas aeruginosa infection.
    Quittner AL; Buu A
    Pediatr Pulmonol; 2002 Apr; 33(4):269-76. PubMed ID: 11921456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with tobramycin solution for inhalation reduces hospitalizations in young CF subjects with mild lung disease.
    Murphy TD; Anbar RD; Lester LA; Nasr SZ; Nickerson B; VanDevanter DR; Colin AA
    Pediatr Pulmonol; 2004 Oct; 38(4):314-20. PubMed ID: 15334509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.
    Lenoir G; Antypkin YG; Miano A; Moretti P; Zanda M; Varoli G; Monici Preti PA; Aryayev NL
    Paediatr Drugs; 2007; 9 Suppl 1():11-20. PubMed ID: 17536871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spirometer-triggered high-resolution computed tomography and pulmonary function measurements during an acute exacerbation in patients with cystic fibrosis.
    Robinson TE; Leung AN; Northway WH; Blankenberg FG; Bloch DA; Oehlert JW; Al-Dabbagh H; Hubli S; Moss RB
    J Pediatr; 2001 Apr; 138(4):553-9. PubMed ID: 11295720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary gas exchange in cystic fibrosis: basal status and the effect of i.v. antibiotics and inhaled amiloride.
    Lagerstrand L; Hjelte L; Jorulf H
    Eur Respir J; 1999 Sep; 14(3):686-92. PubMed ID: 10543293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dornase alfa reduces air trapping in children with mild cystic fibrosis lung disease: a quantitative analysis.
    Robinson TE; Goris ML; Zhu HJ; Chen X; Bhise P; Sheikh F; Moss RB
    Chest; 2005 Oct; 128(4):2327-35. PubMed ID: 16236891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective review of children presenting with non cystic fibrosis bronchiectasis: HRCT features and clinical relationships.
    Edwards EA; Metcalfe R; Milne DG; Thompson J; Byrnes CA
    Pediatr Pulmonol; 2003 Aug; 36(2):87-93. PubMed ID: 12833486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis.
    Moss RB
    Chest; 2002 Jan; 121(1):55-63. PubMed ID: 11796432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tobramycin inhalation powder manufactured by improved process in cystic fibrosis: the randomized EDIT trial.
    Galeva I; Konstan MW; Higgins M; Angyalosi G; Brockhaus F; Piggott S; Thomas K; Chuchalin AG
    Curr Med Res Opin; 2013 Aug; 29(8):947-56. PubMed ID: 23672633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary abnormalities on high-resolution CT demonstrate more rapid decline than FEV1 in adults with cystic fibrosis.
    Judge EP; Dodd JD; Masterson JB; Gallagher CG
    Chest; 2006 Nov; 130(5):1424-32. PubMed ID: 17099020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Composite spirometric-computed tomography outcome measure in early cystic fibrosis lung disease.
    Robinson TE; Leung AN; Northway WH; Blankenberg FG; Chan FP; Bloch DA; Holmes TH; Moss RB
    Am J Respir Crit Care Med; 2003 Sep; 168(5):588-93. PubMed ID: 12746252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of computerized tomography and chest x-rays in evaluating efficacy of aerosolized recombinant human DNase in cystic fibrosis patients younger than age 5 years: a preliminary study.
    Nasr SZ; Kuhns LR; Brown RW; Hurwitz ME; Sanders GM; Strouse PJ
    Pediatr Pulmonol; 2001 May; 31(5):377-82. PubMed ID: 11340684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study to compare tobramycin 80 mg injectable preparation with 300 mg solution for inhalation in cystic fibrosis patients.
    Nikolaizik WH; Vietzke D; Ratjen F
    Can Respir J; 2008; 15(5):259-62. PubMed ID: 18716688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis.
    Gustafsson PM; De Jong PA; Tiddens HA; Lindblad A
    Thorax; 2008 Feb; 63(2):129-34. PubMed ID: 17675316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.
    Ramsey BW; Pepe MS; Quan JM; Otto KL; Montgomery AB; Williams-Warren J; Vasiljev-K M; Borowitz D; Bowman CM; Marshall BC; Marshall S; Smith AL
    N Engl J Med; 1999 Jan; 340(1):23-30. PubMed ID: 9878641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution CT in the acute exacerbation of cystic fibrosis: evaluation of acute findings, reversibility of those findings, and clinical correlation.
    Shah RM; Sexauer W; Ostrum BJ; Fiel SB; Friedman AC
    AJR Am J Roentgenol; 1997 Aug; 169(2):375-80. PubMed ID: 9242738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.